4.5 Editorial Material

The epidemiology of polypharmacy

期刊

CLINICAL MEDICINE
卷 16, 期 5, 页码 465-469

出版社

ROY COLL PHYS LONDON EDITORIAL OFFICE
DOI: 10.7861/clinmedicine.16-5-465

关键词

-

资金

  1. National Institute for Health Research [CL-2010-14-003] Funding Source: researchfish

向作者/读者索取更多资源

Polypharmacy describes, in simplistic terms, the use of multiple medications in an individual. It has become a normal aspect of modern medicine, driven by an ageing, multimorbid population, the increasing availability of preventative medications and an increasing use of single-disease guidelines and adherence to evidence-based practice. However, polypharmacy is also associated with a range of adverse outcomes, and is considered an important and increasing challenge for clinical practice. Here, we consider the definitions of polypharmacy, the extent and nature of medication use in different settings, and the type of problems encountered as a consequence of polypharmacy.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据